Sparo Health

Sparo Health (acquired by Wellinks in 2022) is a digital health company in St. Louis, Missouri committed to transforming respiratory care —from reactive to proactive. Sparo’s flagship product, Wing™ (mywing.io) is the 1st FDA-cleared, over- the-counter smartphone sensor to measure lung function. Sparo has shipped thousands of Wings to customers through initial direct-to-consumer channels and through partnerships and research collaborations, including with Vidant Health System and Washington University in St. Louis. Sparo is now scaling self-pay commercialization efforts in COPD, partnering with top pharmaceutical and population health companies, and developing additional tools and services for improving life with COPD.